However, when residues 174–385 are removed from SUFU, this binding interaction between SUFU and LATS1 is disrupted, which results in the inability of SUFU to downregulate the YAP–ACSL4 axis, consequently resulting in the sensitivity of BC cells [66]. Here, ACSL4 is linked to breast cancer.